In neither the sarcoidosis group nor the control group was there a significant difference in the IgG, IgA, and IgM antibody titers between samples with and without a significant level of PLTA (>105 ng/mL) detected after the pretreatment (Figure 4). The gene discussed is CD79A; the disease is sarcoidosis.